Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2021 | Microglia associated with longevity and a lower AD risk

Dervis Salih • 25 Mar 2021
ARUK 2021
Alzheimer’s Disease

Dervis Salih, PhD, University College London, London, UK, explains the link between life span and the risk of developing Alzheimer’s disease (AD), where certain people who have a longer life span can have normal cognitive function and other people may develop AD in their 70s or 80s. By investigating the variation in people with different life spans, networks with increased microglial expression were associated with longer life spans, strengthening the notion that microglia have protective effects against AD. This interview took place during the Alzheimer’s Research UK (ARUK) Conference 2021.

More from Dervis Salih

The potential druggability of OAS1 leading to new AD and COVID-19 treatments
1:05
The potential druggability of OAS1 leading to new AD and COVID-19 treatments
Dervis Salih • 25 Mar 2021
Identifying innate immune system genes linked to AD
2:58
Identifying innate immune system genes linked to AD
Dervis Salih • 25 Mar 2021
Identifying a new link between TREM2 and IL-4 signaling in microglia
1:31
Identifying a new link between TREM2 and IL-4 signaling in microglia
Dervis Salih • 25 Mar 2021
The OAS1 gene increases risk of AD and COVID-19
2:48
The OAS1 gene increases risk of AD and COVID-19
Dervis Salih • 25 Mar 2021

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
What are the biological mechanisms underlying the higher prevalence of AD in women?
1:55
What are the biological mechanisms underlying the higher prevalence of AD in women?
Amber Watts • 14 Jul 2026
MenoCog: risk and protective factors for cognitive function in the menopause transition
2:37
MenoCog: risk and protective factors for cognitive function in the menopause transition
Amber Watts • 14 Jul 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals